-
Direct contact between tumor cells and platelets initiates a FAK-dependent F3/TGF-β positive feedback loop that promotes tumor progression and EMT in osteosarcoma Cancer Lett. (IF 9.7) Pub Date : 2024-04-18 Qianyu Shi, Jiuhui Xu, Chenglong Chen, Xueyu Hu, Boyang Wang, Fanwei Zeng, Tingting Ren, Yi Huang, Wei Guo, Xiaodong Tang, Tao Ji
Platelets have received growing attention for their roles in hematogenous tumor metastasis. However, the tumor-platelet interaction in osteosarcoma (OS) remains poorly understood. Here, using platelet-specific focal adhesion kinase (FAK)-deficient mice, we uncover a FAK-dependent F3/TGF-β positive feedback loop in OS. Disruption of the feedback loop by inhibition of F3, TGF-β, or FAK significantly
-
Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-18 Jie Luo, Kebin Cheng, Xianxiu Ji, Caixia Gao, Ren Zhu, Jiayi Chen, Wenjun Xue, Qi Huang, Qingqiang Xu
-
Lactate and lactylation: Behind the development of tumors Cancer Lett. (IF 9.7) Pub Date : 2024-04-17 Enci Dai, Wei Wang, Yingying Li, Defeng Ye, Yanli Li
There is growing evidence that lactate can have a wide range of biological impacts in addition to being a waste product of metabolism. Because of the Warburg effect, tumors generate lots of lactate, which create a tumor microenvironment (TME) with low nutrition, hypoxia, and low pH. As a result, the immunosuppressive network is established to gain immune escape potential and regulate tumor growth.
-
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules Cancer Lett. (IF 9.7) Pub Date : 2024-04-16 Marta Banchi, Maria Christina Cox, Guido Bocci
Metronomic chemotherapy (mCHEMO), based on frequent, regular administration of low, but pharmacologically active drug doses, optimizes antitumor efficacy by targeting multiple targets and reducing toxicity of antineoplastic drugs. This minireview will summarize preclinical and clinical studies on cytotoxic drugs given at weekly, daily, or at continuous metronomic schedules alone or in combination with
-
Spatiotemporal characteristics of tissue derived small extracellular vesicles is associated with tumor relapse and anti-PD-1 response Cancer Lett. (IF 9.7) Pub Date : 2024-04-16 Qiu-Yun Fu, Xue-Peng Xiong, Hou-Fu Xia, Xing-Chi Liu, Zi-Li Yu, Kai-Wen Liu, Jun Zeng, Yan-Fang Sun, Jun Jia, Gang Chen
Small extracellular vesicles (sEVs) residing at tumor tissues are valuable specimens for biopsy. Tumor heterogeneity is common across all cancer types, but the heterogeneity of tumor tissue-derived sEVs (Ti-sEVs) is undefined. This study aims to discover the spatial distributions of Ti-sEVs in oral squamous cell carcinoma (OSCC) tissues and explore how these vesicle distributions affect the patients'
-
NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis Cancer Lett. (IF 9.7) Pub Date : 2024-04-16 Renchen Ji, Yuan Wang, Deyue Pan, Jian Han, Yiping Wang, Shuo Zheng, Wenzhi Zhao, Xiaojie Li, Chuanchun Han, Lu Zhang
The oncogenic properties of Nucleobindin2 (NUCB2) have been observed in various cancer types. Nevertheless, the precise understanding of the biological functions and regulatory mechanisms of NUCB2 in osteosarcoma remains limited. This investigation reported that NUCB2 was significantly increased upon glucose deprivation-induced metabolic stress. Elevated NUCB2 suppressed glucose deprivation-induced
-
Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression Cancer Lett. (IF 9.7) Pub Date : 2024-04-16 Wei Wang, Youwei Li, Liu Tang, Yue Shi, Wensheng Li, Ling Zou, Liyuan Zhang, Yue Cheng, Zheng Yuan, Feng Zhu, Qiuhong Duan
-
Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signaling Cancer Lett. (IF 9.7) Pub Date : 2024-04-16 Ying Xin, Bing Hu, Keming Li, Guanshuo Hu, Cunyu Zhang, Xi Chen, Kai Tang, Pengyu Du, Youhua Tan
To seed lethal secondary lesions, circulating tumor cells (CTCs) must survive all rate-limiting factors during hematogenous dissemination, including fluid shear stress (FSS) that poses a grand challenge to their survival. We thus hypothesized that CTCs with the ability to survive FSS in vasculature might hold metastasis-initiating competence. This study reported that FSS of physiologic magnitude selected
-
circRNAs as prognostic markers in pediatric acute myeloid leukemia Cancer Lett. (IF 9.7) Pub Date : 2024-04-15 Huiying Sun, Yangyang Xie, Xiaoyan Wu, Wenting Hu, Xiaoxiao Chen, Kefei Wu, Han Wang, Shuang Zhao, Qiaoqiao Shi, Xiang Wang, Bowen Cui, Wenyan Wu, Rongrong Fan, Jianan Rao, Ronghua Wang, Ying Wang, Ying Zhong, Hui Yu, Binbing S. Zhou, Shuhong Shen, Yu Liu
Circular RNAs (circRNAs) arise from precursor mRNA processing through back-splicing and have been increasingly recognized for their functions in various cancers including acute myeloid leukemia (AML). However, the prognostic implications of circRNA in AML remain unclear. We conducted a comprehensive genome-wide analysis of circRNAs using RNA-seq data in pediatric AML. We revealed a group of circRNAs
-
Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-15 Yuzhao Jin, Jin Jiang, Wei Mao, Minghua Bai, Qianping Chen, Ji Zhu
Radiotherapy (RT) remodels the tumor immune microenvironment (TIME) and modulates the immune response to indirectly destroy tumor cells, in addition to directly killing tumor cells. RT combined with immunotherapy may significantly enhance the efficacy of RT in colorectal cancer by modulating the microenvironment. However, the molecular mechanisms by which RT acts as an immunomodulator to modulate the
-
PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma Cancer Lett. (IF 9.7) Pub Date : 2024-04-13 Jin-Hua Liang, Wei-Ting Wang, Rong Wang, Rui Gao, Kai-Xin Du, Zi-Wen Duan, Xin-Yu Zhang, Yue Li, Jia-Zhu Wu, Hua Yin, Hao-Rui Shen, Li Wang, Jian-Yong Li, Jin-Ran Guo, Wei Xu
Mantle cell lymphoma (MCL) is an incurable and aggressive subtype of non-Hodgkin B-cell lymphoma. Increased lipid uptake, storage, and lipogenesis occur in a variety of cancers and contribute to rapid tumor growth. However, no data has been explored for the roles of lipid metabolism reprogramming in MCL. Here, we identified aberrant lipid metabolism reprogramming and PRMT5 as a key regulator of cholesterol
-
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities Cancer Lett. (IF 9.7) Pub Date : 2024-04-13 Qin Qin, Rong Yu, John E. Eriksson, Hsiang-i Tsai, Haitao Zhu
Pancreatic ductal adenocarcinoma (PDAC) is a solid organ malignancy with a high mortality rate. Statistics indicate that its incidence has been increasing as well as the associated deaths. Most patients with PDAC show poor response to therapies making the clinical management of this cancer difficult. Stromal cells in the tumor microenvironment (TME) contribute to the development of resistance to therapy
-
d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity Cancer Lett. (IF 9.7) Pub Date : 2024-04-12 Wenjing Dong, Mingen Lin, Ruonan Zhang, Xue Sun, Hongchen Li, Tianshu Liu, Yanping Xu, Lei Lv
High expression of programmed cell death protein 1 (PD-1), a typical immune checkpoint, results in dysfunction of T cells in tumor microenvironment. Antibodies and inhibitors against PD-1 or its ligand (PD-L1) have been widely used in various malignant tumors. However, the mechanisms by which PD-1 is regulated are not fully understood. Here, we report a mechanism of PD-1 degradation triggered by -mannose
-
Exhaled volatolomics profiling facilitates personalized screening for gastric cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-12 Jian Chen, Yongyan Ji, Yongqian Liu, Zhengnan Cen, Yuanwen Chen, Yixuan Zhang, Xiaowen Li, Xiang Li
Gastric cancer (GC) is one of the most fatal cancers, characterized by non-specific early symptoms and difficulty in detection. However, there are no valid non-invasive screening tools available for GC. Here we establish a non-invasive method that employs exhaled volatolomics and ensemble learning to detect GC. We developed a comprehensive mass spectrometry-based procedure and determined of a wide
-
The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors Cancer Lett. (IF 9.7) Pub Date : 2024-04-10 Lihong Wang, Lufang Zhang, Louisa Chard Dunmall, Yang Yang Wang, Zaiwen Fan, Zhenguo Cheng, Yaohe Wang
Chimeric antigen receptor T (CAR-T) cell therapy, as an adoptive immunotherapy, is playing an increasingly important role in the treatment of malignant tumors. CAR-T cells are referred to as "living drugs" as they not only target tumor cells directly, but also induce long-term immune memory that has the potential to provide long-lasting protection. CD19.CAR-T cells have achieved complete response rates
-
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies Cancer Lett. (IF 9.7) Pub Date : 2024-04-10 Luke J. Weisbrod, Anand Thiraviyam, Raghupathy Vengoji, Nicole Shonka, Maneesh Jain, Winson Ho, Surinder K. Batra, Afshin Salehi
Diffuse intrinsic pontine glioma (DIPG) is a childhood malignancy of the brainstem with a dismal prognosis. Despite recent advances in its understanding at the molecular level, the prognosis of DIPG has remained unchanged. This article aims to review the current understanding of the genetic pathophysiology of DIPG and to highlight promising therapeutic targets. Various DIPG treatment strategies have
-
FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2 Cancer Lett. (IF 9.7) Pub Date : 2024-04-09 Liyun Zheng, Jiajia Shen, Yang Chen, Jingyu Lin, Pengyu Li, Xiaoli Zhao, Hangjiang Ren, Yi Sun, Zhen Wang
FBXO43 is a member of the FBXO subfamily of F-box proteins, known to be a regulatory hub during meiosis. A body of data showed that FBXO43 is overexpressed in a number of human cancers. However, whether and how FBXO43 affects cell cycle progression and growth of cancer cells remain elusive. In this study, we provide first piece of evidence, showing a pivotal role of FBXO43 in cell cycle progression
-
Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma Cancer Lett. (IF 9.7) Pub Date : 2024-04-09 Kege Yang, Ziyi Zhong, Jinmao Zou, Jian-You Liao, Shaojie Chen, Shurui Zhou, Yue Zhao, Jiajia Li, Dong Yin, Kaihong Huang, Yaqing Li
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies, highlighting the urgent need to elucidate the underlying oncogenic mechanisms. VIRMA is a classic isoform of methyltransferases that participates in epigenetic transcriptomic modification in eukaryotic mRNAs. However, the exact roles of VIRMA in PDAC remain unclear. Here, we identified that VIRMA is highly
-
KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA Cancer Lett. (IF 9.7) Pub Date : 2024-04-07 Ying Lu, Yong Wang, Leilei Zhang, Zhaofeng Ma, Kaitao Yu, Yao Shu, Xuan Zou, Jinjin Yang, Xin Liu, Chenglong Wang, Yimeng Du, Qihong Li
Lysine acetyltransferase 7 (KAT7), a histone acetyltransferase, has recently been identified as an oncoprotein and has been implicated in the development of various malignancies. However, its specific role in head and neck squamous carcinoma (HNSCC) has not been fully elucidated. Our study revealed that high expression of KAT7 in HNSCC patients is associated with poor survival prognosis and silencing
-
Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1 Cancer Lett. (IF 9.7) Pub Date : 2024-04-07 Xin Zhou, Kaini Zhang, Chen Wang, Yunfei Teng, Peihong Yu, Wei Cai, Wenjie Gao, Min Li, Ying Ding, Peng Sun, Fang Chen, Yipin Wang, Juan Ma, Noriaki Maeshige, Xiaoqi Ma, Qingguo Li, Xiubin Liang, Yaqin Zhang, Dongming Su
While previous studies have indicated the involvement of Isthmin 1 (ISM1), a secreted protein, in cancer development, the precise mechanisms have remained elusive. In this study, we unveiled that ISM1 is significantly overexpressed in both the blood and tissue samples of colorectal cancer (CRC) patients, correlating with their poor prognosis. Functional experiments demonstrated that enforced ISM1 expression
-
Osteocytes support bone metastasis of melanoma cells by CXCL5 Cancer Lett. (IF 9.7) Pub Date : 2024-04-06 Yewei Jia, Fulin Zhang, Xianyi Meng, Darja Andreev, Pang Lyu, Wenshuo Zhang, Chaobo Lai, Georg Schett, Aline Bozec
-
TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma Cancer Lett. (IF 9.7) Pub Date : 2024-04-06 Linglu Wang, Xiaoyan Liu, Yuhang Han, Hsiang-i Tsai, Zilin Dan, Peiru Yang, Zhanxue Xu, Fan Shu, Chao He, John E. Eriksson, Haitao Zhu, Hongbo Chen, Fang Cheng
Immunotherapy represented by programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) monoclonal antibodies has led tumor treatment into a new era. However, the low overall response rate and high incidence of drug resistance largely damage the clinical benefits of existing immune checkpoint therapies. Recent studies correlate the response to PD-1/PD-L1 blockade with PD-L1 expression
-
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-06 Etienne J. Slapak, Mouad el Mandili, Marieke S. Ten Brink, Alexander Kros, Maarten F. Bijlsma, C. Arnold Spek
Pancreatic adenocarcinoma (PDAC) is highly resistant to conventional chemotherapeutic interventions, resulting in exceptionally low survival rates. The limited efficacy can in part be attributed to dose limitations and treatment cessation urged by toxicity of currently used chemotherapy. The advent of targeted delivery strategies has kindled hope for circumventing off-target toxicity. We have previously
-
Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy Cancer Lett. (IF 9.7) Pub Date : 2024-04-05 Wen Wen, Yavuz Nuri Ertas, Ahmet Erdem, Yao Zhang
-
Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics Cancer Lett. (IF 9.7) Pub Date : 2024-04-05 Yuxuan Song, Shuang Ren, Xingmei Chen, Xuhong Li, Lin Chen, Shijie Zhao, Yue Zhang, Xiangchun Shen, Yan Chen
Tamoxifen (TAM) resistance presents a major clinical obstacle in the management of estrogen-sensitive breast cancer, highlighting the need to understand the underlying mechanisms and potential therapeutic approaches. We showed that dysregulated mitochondrial dynamics were involved in TAM resistance by protecting against mitochondrial apoptosis. The dysregulated mitochondrial dynamics were associated
-
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions Cancer Lett. (IF 9.7) Pub Date : 2024-04-05 Qiang Yu, Jiajun Ding, Shisen Li, Yunlong Li
-
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability Cancer Lett. (IF 9.7) Pub Date : 2024-04-04 Feihu Zhao, Zhong Yao, Yaquan Li, Wenbo Zhao, Yanfei Sun, Xiaobing Yang, Zhimin Zhao, Bin Huang, Jian Wang, Xingang Li, Anjing Chen
Proper protein folding relies on the assistance of molecular chaperones post-translation. Dysfunctions in chaperones can cause diseases associated with protein misfolding, including cancer. While previous studies have identified CCT2 as a chaperone subunit and an autophagy receptor, its specific involvement in glioblastoma remains unknown. Here, we identified CCT2 promote glioblastoma progression.
-
Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities Cancer Lett. (IF 9.7) Pub Date : 2024-04-04 Srimanta Patra, Prajna Paramita Naik, Kewal Kumar Mahapatra, Moureq Rashed Alotaibi, Shankargouda Patil, Birija Sankar Patro, Gautam Sethi, Thomas Efferth, Sujit Kumar Bhutia
Recurrent chemotherapy-induced senescence and resistance are attributed to the polyploidization of cancer cells that involve genomic instability and poor prognosis due to their unique form of cellular plasticity. Autophagy, a pre-dominant cell survival mechanism, is crucial during carcinogenesis and chemotherapeutic stress, favouring polyploidization. The selective autophagic degradation of essential
-
SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG Cancer Lett. (IF 9.7) Pub Date : 2024-04-04 Kangdi Li, Han Lin, Anyi Liu, Cheng Qiu, Zejun Rao, Zhihong Wang, Siqi Chen, Xiaowei She, Shengyu Zhu, Pengcheng Li, Lang Liu, Qi Wu, Guihua Wang, Feng Xu, Shaotang Li
Platinum-based neoadjuvant therapy represented by cisplatin is widely employed in treating Triple-Negative Breast Cancer (TNBC), a particularly aggressive subtype of breast cancer. Nevertheless, the emergence of cisplatin resistance presents a formidable challenge to clinical chemotherapy efficacy. Herein, we revealed the critical role of tumor microenvironment (TME) derived exosomal miR-3960 and phosphorylation
-
Colorectal cancer initiation: Understanding early-stage disease for intervention Cancer Lett. (IF 9.7) Pub Date : 2024-04-03 Chao Jiang, Qiujing Zhou, Ke Yi, Ying Yuan, Xin Xie
How tumors arise or the cause of precancerous lesions is a fundamental question in cancer biology. It is generally accepted that tumors originate from normal cells that undergo uncontrolled proliferation owing to genetic alterations. At the onset of adenoma formation, cancer driver mutations confer clonal growth advantage, enabling mutant cells to outcompete and eliminate the surrounding healthy cells
-
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-03 Esin Orhan, Carolina Velazquez, Imene Tabet, Lise Fenou, Geneviève Rodier, Béatrice Orsetti, William Jacot, Claude Sardet, Charles Theillet
One in three Triple Negative Breast Cancer (TNBC) is Homologous Recombination Deficient (HRD) and susceptible to respond to PARP inhibitor (PARPi), however, resistance resulting from functional HR restoration is frequent. Thus, pharmacologic approaches that induce HRD are of interest. We investigated the effectiveness of CDK-inhibition to induce HRD and increase PARPi sensitivity of TNBC cell lines
-
LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-02 Gui-Bin Gao, Liang Chen, Jia-Feng Pan, Tao Lei, Xin Cai, Zhexue Hao, Qi Wang, Ge Shan, Jin Li
Ferroptosis, an iron-dependent regulated cell death caused by excessive lipid peroxide accumulation, has emerged as a promising therapeutic target in various cancers, including non-small cell lung cancer (NSCLC). In this study, we identified the long non-coding RNA RGMB-AS1 as a key regulator of ferroptosis in NSCLC. Mechanistically, RGMB-AS1 interacted with heme oxygenase 1 (HMOX1) and prevented its
-
JAML promotes the antitumor role of tumor-resident CD8+ T cells by facilitating their innate-like function in human lung cancer Cancer Lett. (IF 9.7) Pub Date : 2024-04-01 Zhixing Hao, Zhongwei Xin, Yongyuan Chen, Zheyu Shao, Wei Lin, Wenxuan Wu, Mingjie Lin, Qinyuan Liu, Di Chen, Dang Wu, Pin Wu
Tissue-resident memory CD8+T cells (CD8+TRMs) are thought to play a crucial role in cancer immunosurveillance. However, the characteristics of CD8+TRMs in the tumor microenvironment (TME) of human non-small cell lung cancer (NSCLC) remain unclear. Here, we report that CD8+TRMs accumulate explicitly and exhibit a unique gene expression profile in the TME of NSCLC. Interestingly, these tumor-associated
-
Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma Cancer Lett. (IF 9.7) Pub Date : 2024-03-30 Ruining Gong, Jia Wang, Yihai Xing, Jigang Wang, Xianghan Chen, Ke Lei, Qian Yu, Chenyang Zhao, Sainan Li, Yuxing Zhang, Hongxia Wang, He Ren
FOXP3, a key identifier of Treg, has also been identified in tumor cells, which is referred to as cancer-FOXP3 (-FOXP3). Human -FOXP3 undergoes multiple alternative splicing events, generating several isoforms, like -FOXP3FL and -FOXP3Δ3. Previous research on -FOXP3 often ignore its cellular source (immune or tumor cells) and isoform expression patterns, which may obscure our understanding of its clinical
-
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer Cancer Lett. (IF 9.7) Pub Date : 2024-03-30 Yi Zhou, Huali Li, Yaxin Zhang, Enen Zhao, Chengmei Huang, Xingyan Pan, Feng Shu, Zhihao Liu, Na Tang, Fengtian Li, Wenting Liao
Despite the approval of immune checkpoint blockade (ICB) therapy for various tumor types, its effectiveness is limited to only approximately 15% of patients with microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR) colorectal cancer (CRC). Approximately 80%–85% of CRC patients have a microsatellite stability (MSS) phenotype, which features a rare T-cell infiltration. Thus, elucidating
-
PGR-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells Cancer Lett. (IF 9.7) Pub Date : 2024-03-30 Zeyu Yang, Hongdan Chen, Supeng Yin, Hongbiao Mo, Fan Chai, Peng Luo, Yao Li, Le Ma, Ziying Yi, Yizeng Sun, Yan Chen, Jie Wu, Weihua Wang, Tingjie Yin, Junping Zhu, Chunmeng Shi, Fan Zhang
The immune microenvironment constructed by tumor-infiltrating immune cells and the molecular phenotype defined by hormone receptors (HRs) have been implicated as decisive factors in the regulation of breast cancer (BC) progression. Here, we found that the infiltration of mast cells (MCs) informed impaired prognoses in HR(+) BC but predicted improved prognoses in HR(−) BC. However, molecular features
-
Is it time to discard the Diagnostic and Statistical Manual of Mental Disorders (DSM) in psycho-oncology? Cancer Lett. (IF 9.7) Pub Date : 2024-03-28 Darren Haywood, Roman Kotov, Robert F. Krueger, Aidan G.C. Wright, Miriam K. Forbes, Evan Dauer, Frank D. Baughman, Susan L. Rossell, Nicolas H. Hart
-
IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation Cancer Lett. (IF 9.7) Pub Date : 2024-03-27 Yikang Ji, Zhen Zhang, Xinran Zhao, Zhiyin Li, Xin Hu, Mi Zhang, Xinhua Pan, Xu Wang, Wantao Chen
Understanding the intrinsic mechanisms underpinning cancer metabolism and therapeutic resistance is of central importance for effective nutrition-starvation therapies. Here, we report that () mRNA and IL-1α protein facilitate glutathione (GSH) synthesis to counteract oxidative stress and resistance against nutrition-starvation therapy in oral squamous cell carcinoma (OSCC). The expression of mRNA was
-
Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer Cancer Lett. (IF 9.7) Pub Date : 2024-03-27 Jiatong Lin, Wenhui Zhong, Zejian Lyu, Jingwen Peng, Yi Rong, Kejing Zeng, Jianguo Lai, Deqing Wu, Junjiang Wang, Yong Li, Jun Zheng, Jianwei Zhang, Zihao Pan
As one of the key metabolic enzymes in the glycolytic pathway, lactate dehydrogenase A (LDHA) might be linked to tumor proliferation by driving the Warburg effect. Circular RNAs (circRNAs) are widely implicated in tumor progression. Here, we report that circTATDN3, a circular RNA that interacts with LDHA, plays a critical role in proliferation and energy metabolism in CRC. We found that circTATDN3
-
The emerging role of lactate in tumor microenvironment and its clinical relevance Cancer Lett. (IF 9.7) Pub Date : 2024-03-26 Sihan Chen, Yining Xu, Wei Zhuo, Lu Zhang
In recent years, the significant impact of lactate in the tumor microenvironment has been greatly documented. Acting not only as an energy substance in tumor metabolism, lactate is also an imperative signaling molecule. It plays key roles in metabolic remodeling, protein lactylation, immunosuppression, drug resistance, epigenetics and tumor metastasis, which has a tight relation with cancer patients’
-
Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer Cancer Lett. (IF 9.7) Pub Date : 2024-03-26 Zhou Zhao, Zhaolun Cai, Su Zhang, Xiaonan Yin, Tianxiang Jiang, Chaoyong Shen, Yuan Yin, Hao Sun, Zhixin Chen, Junhong Han, Bo Zhang
Nucleosome assembly during DNA replication is dependent on histone chaperones. Recent studies suggest that dysregulated histone chaperones contribute to cancer progression, including gastric cancer (GC). Further studies are required to explore the prognostic and therapeutic implications of histone chaperones and their mechanisms of action in GC progression. Here we identified histone chaperone ASF1B
-
USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop Cancer Lett. (IF 9.7) Pub Date : 2024-03-26 Huanye Mo, Runtian Li, Nan Yang, Jiaqi Han, Xuelian Xiao, Yilei Zhang, Zhengtao Xiao, Lianying Jiao, Qiuran Xu, Kangsheng Tu
Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regulator of YAP abundance and its target genes in HCC cells. USP40 interacted with YAP to remove the lysine
-
OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses Cancer Lett. (IF 9.7) Pub Date : 2024-03-25 Yi Zheng, Xiaomin Wang, Qiang Ji, Aizhong Fang, Lairong Song, Xiaoying Xu, Yi Lin, Yichen Peng, Jianyu Yu, Lei Xie, Feng Chen, Xiaojie Li, Sipeng Zhu, Botao Zhang, Lili Zhou, Chunna Yu, YaLi Wang, Liang Wang, Han Hu, Ziyi Zhang, Binlei Liu, Zhen Wu, Wenbin Li
Glioblastoma (GBM), the deadliest central nervous system cancer, presents a poor prognosis and scant therapeutic options. Our research spotlights OH2, an oncolytic viral therapy derived from herpes simplex virus 2 (HSV-2), which demonstrates substantial antitumor activity and favorable tolerance in GBM. The extraordinary efficacy of OH2 emanates from its unique mechanisms: it selectively targets tumor
-
Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis Cancer Lett. (IF 9.7) Pub Date : 2024-03-23 Po-Shun Wang, Zulong Liu, Osama Sweef, Abdullah Farhan Saeed, Thomas Kluz, Max Costa, Kenneth R. Shroyer, Kazuya Kondo, Zhishan Wang, Chengfeng Yang
Lung cancer is the leading cause of cancer-related death worldwide; however, the mechanism of lung carcinogenesis has not been clearly defined. Chronic exposure to hexavalent chromium [Cr(VI)], a common environmental and occupational pollutant, causes lung cancer, representing an important lung cancer etiology factor. The mechanism of how chronic Cr(VI) exposure causes lung cancer remains largely unknown
-
LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3 Cancer Lett. (IF 9.7) Pub Date : 2024-03-22 Zhonglin Zhu, Minghan Li, Junyong Weng, Shanbao Li, Tianan Guo, Yang Guo, Ye Xu
5-Fluorouracil (5-FU) resistance has always been a formidable obstacle in the adjuvant treatment of advanced colorectal cancer (CRC). In recent years, long non-coding RNAs have emerged as key regulators in various pathophysiological processes including 5-FU resistance. TRG is a postoperative pathological score of the chemotherapy effectiveness for CRC, of which TRG 0–1 is classified as chemotherapy
-
Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer Cancer Lett. (IF 9.7) Pub Date : 2024-03-22 Dongze Zhang, Jinjing Xie, Fangxin Sun, Ruyan Xu, Wenjun Liu, Jia Xu, Xue Huang, Guangbo Zhang
Immunotherapy aimed at inhibiting the negative co-stimulatory molecule programmed cell death-ligand 1 (PD-L1) has limited effectiveness, with clinical response rates remaining below 10%–15%. Therefore, new immune checkpoints need to be explored. Our study focused on human endogenous retrovirus H long terminal repeat–associating protein 2 (HHLA2), a highly glycosylated member of the B7 family that is
-
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming Cancer Lett. (IF 9.7) Pub Date : 2024-03-22 Ting Yu, Zhaoyun Liu, Qingxu Tao, Xin Xu, Xinyang Li, Yang Li, Minxin Chen, Rufei Liu, Dawei Chen, Meng Wu, Jinming Yu
Immunotherapy, especially immune checkpoint inhibitors, has revolutionized clinical practice within the last decade. However, primary and secondary resistance to immunotherapy is common in patients with diverse types of cancer. It is well-acknowledged that tumor cells can facilitate the formation of immunosuppressive microenvironments via metabolism reprogramming, and lactic acid, the metabolite of
-
Hypoxia-associated autophagy flux dysregulation in human cancers Cancer Lett. (IF 9.7) Pub Date : 2024-03-21 Jiding Fu, Jie Lin, Zili Dai, Baisheng Lin, Jian Zhang
-
Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis Cancer Lett. (IF 9.7) Pub Date : 2024-03-21 Kyoko Hisano, Yusuke Mizuuchi, Kenoki Ohuchida, Jun Kawata, Nobuhiro Torata, Jinghui Zhang, Naoki Katayama, Chikanori Tsutsumi, Shoichi Nakamura, Sho Okuda, Yoshiki Otsubo, Koji Tamura, Kinuko Nagayoshi, Naoki Ikenaga, Koji Shindo, Kohei Nakata, Yoshinao Oda, Masafumi Nakamura
Familial adenomatous polyposis (FAP) is a heritable disease that increases the risk of colorectal cancer (CRC) development because of heterozygous mutations in Little is known about the microenvironment of FAP. Here, single-cell RNA sequencing was performed on matched normal tissues, adenomas, and carcinomas from four patients with FAP. We analyzed the transcriptomes of 56,225 unsorted single cells
-
Treatments on the horizon for locally advanced basal cell carcinoma Cancer Lett. (IF 9.7) Pub Date : 2024-03-21 Munir H. Idriss, Carolyn M. Stull, Michael R. Migden
Basal cell carcinoma (BCC) is one of the most common human cancers. Most cases of BCC are amenable to surgical and topical treatments with excellent prognosis if diagnosed timely and managed appropriately. However, in a small percentage of cases, it could be locally advanced BBC (laBCC) and not amenable to surgery or radiation, including recurrent, large tumors or tumors that invade deeper tissue.
-
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis Cancer Lett. (IF 9.7) Pub Date : 2024-03-19 Jing Yang, Xin Liu, Qiu-Zi Zhong, Yong Yang, Tao Wu, Si-Ye Chen, Bo Chen, Yong-Wen Song, Hui Fang, Shu-Lian Wang, Yue-Ping Liu, Jing Jin, Ning Li, Ning-Ning Lu, Hao Jing, Yuan Tang, Fan Chen, Xi-Mei Zhang, Wenwen Zhang, Yirui Zhai, Shu-Nan Qi, Ye-Xiong Li
This study was to report proxy measures for mortality risk in patients with hematological malignancies across 185 countries globally and explore its association with their socioeconomic status and treatment. The incidence, mortality, and 5-year prevalence data were extracted from the GLOBOCAN database. The data regarding the human development index (HDI), gross national income (GNI), vulnerability
-
Candida albicans-myeloid cells-T lymphocytes axis in the tumor microenvironment of oral tumor-bearing mice Cancer Lett. (IF 9.7) Pub Date : 2024-03-17 Xu Wang, Tiansong Xu, Shuangshuang Wu, Linman Li, Xinjia Cai, Feng Chen, Zhimin Yan
() is associated with the development of oral cancer. Here, we report the altered tumor microenvironment in oral tumor-bearing mice caused by infection. Single-cell RNA sequencing showed that . infection influenced the tumor microenvironment significantly. Specifically, infection reduced the CD8 T cells but increased the IL-17A CD4 T cells and IL-17A γδ T cells in oral tumor. The neutralization of
-
Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies Cancer Lett. (IF 9.7) Pub Date : 2024-03-16 Etsuko Yokota, Miki Iwai, Takuro Yukawa, Yoshio Naomoto, Minoru Haisa, Yasumasa Monobe, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Pulmonary large-cell neuroendocrine carcinoma (LCNEC), a disease with poor prognosis, is classified as pulmonary high-grade neuroendocrine carcinoma, along with small-cell lung cancer. However, given its infrequent occurrence, only a limited number of preclinical models have been established. Here, we established three LCNEC tumoroids for long-term culture. Whole-exome sequencing revealed that these
-
An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC Cancer Lett. (IF 9.7) Pub Date : 2024-03-16 Wei Zheng, Hui Yuan, Yuxia Fu, Guodong Deng, Xuejing Zheng, Lei Xu, Hongjun Fan, Wei Jiang, Xiying Yu
Rat model of N-nitrosomethylbenzylamine (NMBzA)-induced esophageal squamous cell carcinoma (ESCC) is routinely used to study ESCC initiation, progression and new therapeutic strategies. However, the model is time-consuming and malignant tumor incidences are low. Here, we report the usage of multi-kinase inhibitor sorafenib as a tumor promoter to establish an efficient two-stage NMBzA-induced rat ESCC
-
Engineered bacteria in tumor immunotherapy Cancer Lett. (IF 9.7) Pub Date : 2024-03-15 Hua Chen, Yinrui Zhu, Chonghai Zhang, Lin Hu, Kai Yang
As the limitations of cancer immunotherapy become increasingly apparent, there is considerable anticipation regarding the utilization of biological tools to enhance treatment efficacy, particularly bacteria and their derivatives. Leveraging advances in genetic and synthetic biology technologies, engineered bacteria now play important roles far beyond those of conventional immunoregulatory agents, and
-
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer Cancer Lett. (IF 9.7) Pub Date : 2024-03-15 Chandra Kumar Elechalawar, Suresh Kumar Gulla, Ram Vinod Roy, Nicolas Means, Yushan Zhang, Sima Asifa, David J. Robertson, Chao Xu, Resham Bhattacharya, Priyabrata Mukherjee
Pancreatic cancer is characterized by desmoplasia; crosstalk between pancreatic cancer cells (PCCs) and pancreatic stellate cells (PSCs) leads to the deposition of extracellular matrix proteins in the tumor environment resulting in poor vascularity. Targeting either PCCs or PSCs individually has produced mixed results, and there is currently no effective strategy to target both cell types simultaneously
-
Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma Cancer Lett. (IF 9.7) Pub Date : 2024-03-15 Jin Woo Moon, Beom-Jin Hong, Seon-Kyu Kim, Min-Seok Park, Hohyeon Lee, JiWon Lee, Mi-Young Kim
Metastatic lung adenocarcinoma (LuAC) presents a significant clinical challenge due to the short latency and the lack of efficient treatment options. Therefore, identification of molecular vulnerabilities in metastatic LuAC holds great importance in the development of therapeutic drugs against this disease. In this study, we performed a genome-wide siRNA screening using poorly and highly brain-metastatic
-
Poly-pharmacology of existing drugs: How to crack the code? Cancer Lett. (IF 9.7) Pub Date : 2024-03-14 Baptiste Mouysset, Marion Le Grand, Luc Camoin, Eddy Pasquier
Drug development in oncology is highly challenging, with less than 5% success rate in clinical trials. This alarming figure points out the need to study in more details the multiple biological effects of drugs in specific contexts. Indeed, the comprehensive assessment of drug poly-pharmacology can provide insights into their therapeutic and adverse effects, to optimize their utilization and maximize
-
Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma Cancer Lett. (IF 9.7) Pub Date : 2024-03-13 Shuimei Luo, Yang Luo, Ziming Wang, Haofeng Yin, Qing Wu, Xiaowei Du, Xianhe Xie
Super-enhancers (SEs) exerted a crucial role in regulating the transcription of oncogenes across various malignancies while the roles of SEs driven genes and the core regulatory elements remain elusive in LUAD. In this study, cancer-specific-SE-genes of lung adenocarcinoma (LUAD) were profiled through H3K27ac ChIP-seq data of cancer cell lines and normal lung tissues, which enriched in in biological
-
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma Cancer Lett. (IF 9.7) Pub Date : 2024-03-13 Eryan Yang, Biao Hong, Yunfei Wang, Qixue Wang, Jixing Zhao, Xiaoteng Cui, Ye Wu, Shixue Yang, Dongyuan Su, Xiaomin Liu, Chunsheng Kang
The efficacy of temozolomide (TMZ) treatment in glioblastoma (GBM) is influenced by various mechanisms, mainly including the level of O-methylguanine-DNA methyltransferase (MGMT) and the activity of DNA damage repair (DDR) pathways. In our previous study, we had proved that long non-coding RNA HOTAIR regulated the GBM progression and mediated DDR by interacting with EZH2, the catalytic subunit of PRC2